Patent · US Expired

HIV-3 retrovirus and its use

US6013484A · kind A · utility

2Cited by

4References

12Claims

0Family size

Assignee

Innogenetics N.V. · BE

Inventors

Robert De Leys · Grimbergen, BE
Bart Vanderborght · Geel, BE
Eric Saman · Bornem, BE
Hugo Van Heuverswyn · Laarne, BE

Key dates

Filing date	Jul 25, 1997
Grant date	Jan 11, 2000
Priority date	—
Expiry date	Jul 25, 2017

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/809
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described is a new variety of retrovirus designated HIV-3, samples of which are deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301. Further described are antigens obtained from the virus, particularly proteins p12, p16, p25 and glycoproteins gp41 and gp120 to be used in the diagnosis of ARC or AIDS caused by HIV-3. Immunogenic compositions to be used as vaccines contain an envelope glycoprotein of HIV-3 such as gp41 or gp120.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.